Patent intelligence · US
US 6288040
Medicament excipient particles for tissue-specific application of a medicament
Medicament excipient particles for tissue-specific application of a medicament
Patent details — US 6288040
- Jurisdiction
- US
- Status
- expired
- Grant date
- Sep 11, 2001
- Expiration
- Sep 6, 2021
- Claims
- 55
- CPC classes
- A61K, A61K9/5073, A61K9/5138, A61P
Quick answer
US 6288040 (Medicament excipient particles for tissue-specific application of a medicament) is held by DSS Drug Delivery Service Gesellschaft zur Forderung der Foshung In Phamazeutischer Technologi und Biopharmazie mbH. Status: expired. Granted Sep 11, 2001. Expires Sep 6, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 55
- CPC classes
- A61K, A61K9/5073, A61K9/5138, A61P, A61P25/00
More from DSS Drug Delivery Service Gesellschaft zur Forderung der Foshung In Phamazeutischer Technologi und Biopharmazie mbH
Related pharmaceutical patents in our USPTO index.
-
US 12310943
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 12297182
Compositions comprising an urolithin compound
granted -
US 12226455
Medical composition for treating cardiac wasting and cachexia
granted -
US 12220424
Compositions comprising nicotinamide riboside and a urolithin
granted -
US 12109190
Urolithins as immune response enhancers
granted -
US 12036205
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 12030863
Prodrugs of urolithins and uses thereof
granted -
US 11969408
Method for improving mitophagy in subjects
granted
Frequently asked questions
What is US patent 6288040?
US 6288040 (Medicament excipient particles for tissue-specific application of a medicament) is held by DSS Drug Delivery Service Gesellschaft zur Forderung der Foshung In Phamazeutischer Technologi und Biopharmazie mbH. Status: expired. Granted Sep 11, 2001. Expires Sep 6, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6288040?
DSS Drug Delivery Service Gesellschaft zur Forderung der Foshung In Phamazeutischer Technologi und Biopharmazie mbH is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 60 pharmaceutical patents for this assignee.
When does US 6288040 expire?
Our index shows an expiration date of Sep 6, 2021 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.